Project Grant 2208433

Award Date 1/15/23
Completion Date 12/31/23
Dollars Obligated $256K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Seal Beach, CA 90740, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $999,545 to Senoguard Inc., a woman-owned small business located in Seal Beach, CA, is supporting the development and testing of a novel minimally invasive cryogenic probe for post-lumpectomy margin ablation treatment. The project aims to complete engineering and validation activities for this cryoablation probe, which will be coupled with an external cryoagent controller,...
The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I project grant to Agil Therapeutics Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). This two-year project aims to develop a novel cryoablation system for minimally invasive treatment of type 2 diabetes. The system is designed to deliver a highly controlled and targeted cryogenic agent to the duodenum, with the goal of remodeling the duodenal tissue to...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Theromics Inc., a minority-owned small disadvantaged business, aims to develop a novel protein-based gel to improve the effectiveness and safety of thermal tumor ablation procedures. The project will involve creating a computational model to predict the thermal behavior of the gel, conducting preclinical studies to quantify temperatures, ablation zone size,...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This $305,000 National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) award supports the development of an innovative breast cancer screening technology by Bired Imaging Inc., a for-profit organization located in Rochester, NY. The project aims to improve early detection of breast cancer, especially in women with dense breast tissue, by using infrared imaging and physics-based AI algorithms to detect malignant...
This $274,990 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel optical method for detecting microscopic tumors to enable more rapid and accurate point-of-care cancer diagnoses. The project aims to integrate plasmonic nanobubble sensors into a medical device platform and endoscope to perform minimally invasive, non-invasive cancer diagnostic procedures. The key product being...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Oncoblaze LLC to develop a novel medical device for targeted chemotherapy delivery to treat cancer tumor recurrence. The project aims to create a device prototype that uses an infrared laser to precisely heat and trigger the release of chemotherapy drugs in the tissue surrounding a surgically removed tumor. The device will also...
The National Science Foundation (NSF) awarded a $274,750 Small Business Innovation Research (SBIR) Phase I grant to Amplified Sciences Inc. on March 15, 2024 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a surface-enhanced Raman spectroscopy (SERS)-based diagnostic platform to detect and monitor multiple inflammatory biomarkers associated with various cancers. Key objectives include: 1) synthesizing ultrasensitive SERS-active dye...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Ihnnova LLC aims to advance the development and evaluation of hand-held induction heaters for magnetic fluid hyperthermia (MFH) treatment of pancreatic and prostate cancer. The project seeks to enable MFH treatment for patients with metallic implants who are currently ineligible due to compatibility issues. The key objectives are to (a) develop methods to deliver...

The National Science Foundation awarded a $255,731 Small Business Innovation Research Phase I Project Grant to Senoguard Inc. under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funds the development and preclinical testing of a novel cryoablation probe system for post-lumpectomy margin ablation cancer treatment. Specifically, the company will design and optimize the probe for optimal contact and thermal transfer with tumor cells in fixed in vitro testing. The goal is to validate the probe design can kill breast cancer cells with over 99% accuracy using an accepted animal cellular tumor model. If successful, results could support further preclinical product research and development prior to human use of the system. The cryoablation technology aims to provide a more effective and less invasive alternative to radiation therapy following breast lumpectomies.

Generated 1/6/24, 7:06 PM